Your browser doesn't support javascript.
loading
The anticancer peptide RT53 induces immunogenic cell death.
Pasquereau-Kotula, Ewa; Habault, Justine; Kroemer, Guido; Poyet, Jean-Luc.
Affiliation
  • Pasquereau-Kotula E; INSERM UMRS1160, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
  • Habault J; INSERM UMRS1160, Institut Universitaire d'Hématologie, Hôpital Saint-Louis, Paris, France.
  • Kroemer G; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • Poyet JL; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France.
PLoS One ; 13(8): e0201220, 2018.
Article in En | MEDLINE | ID: mdl-30080874
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Nuclear Proteins / Cell Death / Apoptosis Regulatory Proteins / Cell-Penetrating Peptides / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Nuclear Proteins / Cell Death / Apoptosis Regulatory Proteins / Cell-Penetrating Peptides / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Document type: Article Affiliation country: France Country of publication: United States